Kristen N Ganjoo

Kristen N Ganjoo

UNVERIFIED PROFILE

Are you Kristen N Ganjoo?   Register this Author

Register author
Kristen N Ganjoo

Kristen N Ganjoo

Publications by authors named "Kristen N Ganjoo"

Are you Kristen N Ganjoo?   Register this Author

46Publications

1140Reads

21Profile Views

A clinico-genomic analysis of soft tissue sarcoma patients reveals CDKN2A deletion as a biomarker for poor prognosis.

Clin Sarcoma Res 2019 11;9:12. Epub 2019 Sep 11.

1Department of Medicine (Oncology), Stanford University School of Medicine, 875 Blake Wilbur Drive, Stanford, CA 94305 USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13569-019-0122-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6739971PMC
September 2019

Uterine sarcomas.

Authors:
Kristen N Ganjoo

Curr Probl Cancer 2019 Aug 14;43(4):283-288. Epub 2019 Jun 14.

Stanford Cancer Institute, Stanford, California. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.currproblcancer.2019.06.001DOI Listing
August 2019

Randomized Double-Blind Phase II Study of Regorafenib in Patients With Metastatic Osteosarcoma.

J Clin Oncol 2019 Jun 23;37(16):1424-1431. Epub 2019 Apr 23.

16 Monter Cancer Center, Northwell Health, Lake Success, NY, and Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.18.02374DOI Listing
June 2019

The impact of postoperative therapy on primary cardiac sarcoma.

J Thorac Cardiovasc Surg 2018 12 6;156(6):2194-2203. Epub 2018 Jun 6.

Department of Medicine (Oncology), Stanford University School of Medicine, Stanford, Calif. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtcvs.2018.04.127DOI Listing
December 2018

Aldoxorubicin therapy for the treatment of patients with advanced soft tissue sarcoma.

Future Oncol 2018 Oct 5;14(23):2323-2333. Epub 2018 Jun 5.

Department of Medical Oncology, Stanford Cancer Institute, Stanford, CA 94304, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2018-0047DOI Listing
October 2018

Anaplastic Thyroid Cancer With Extensive Skeletal Muscle Metastases on 18F-FDG PET/CT.

Clin Nucl Med 2018 Apr;43(4):e113-e114

From the Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Stanford University, Stanford, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RLU.0000000000001968DOI Listing
April 2018

Concurrent Imatinib and Radiation Therapy for Unresectable and Symptomatic Desmoid Tumors.

Sarcoma 2017 5;2017:2316839. Epub 2017 Jul 5.

Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2017/2316839DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516706PMC
July 2017

Denosumab, a Potential Alternative to the Surgical Treatment of Distal Radius Giant Cell Tumor of Bone: Case Report.

J Hand Surg Am 2015 Aug 29;40(8):1620-4. Epub 2015 Apr 29.

Robert A Chase Hand and Upper Limb Center, Stanford Hospitals and Clinics, Redwood City, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhsa.2015.03.018DOI Listing
August 2015

Leiomyosarcoma: One disease or distinct biologic entities based on site of origin?

J Surg Oncol 2015 Jun;111(7):808-12

Department of Surgery, Stanford University Medical Center, Stanford, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jso.23904DOI Listing
June 2015

Phase II study of the safety and antitumor activity of the hypoxia-activated prodrug TH-302 in combination with doxorubicin in patients with advanced soft tissue sarcoma.

J Clin Oncol 2014 Oct 2;32(29):3299-306. Epub 2014 Sep 2.

Sant P. Chawla, Sarcoma Oncology Center, Santa Monica; Andrew E. Hendifar, Cedars Sinai Medical Center, Los Angeles; Stew Kroll, Threshold Pharmaceuticals, South San Francisco; Kristen N. Ganjoo, Stanford University Medical Center, Stanford, CA; Lee D. Cranmer, University of Arizona Cancer Center, Tucson, AZ; Brian A. Van Tine and Douglas R. Adkins, Washington University in St Louis, St Louis, MO; Damon R. Reed, Moffitt Cancer Center and Research Institute, Tampa, FL; Scott H. Okuno, Mayo Clinic, Rochester, MN; and James E. Butrynski, Dana-Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.54.3660DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4588714PMC
October 2014

Active idiotypic vaccination versus control immunotherapy for follicular lymphoma.

J Clin Oncol 2014 Jun 5;32(17):1797-803. Epub 2014 May 5.

Ronald Levy, Andrew J. Gentles, Chih Long Liu, Robert Tibshirani, and Ash A. Alizadeh, Stanford University Medical Center, Palo Alto; Christos E. Emmanouilides and John M. Timmerman, University of California Los Angeles Medical Center, Los Angeles; Lori A. Kunkel, Diane E. Ingolia, and Dan W. Denney Jr, Genitope, Fremont, CA; Kristen N. Ganjoo and Michael J. Robertson, Indiana University Medical Center, Indianapolis, IN; John P. Leonard, Weill Medical College of Cornell University, New York, NY; Julie M. Vose, University of Nebraska Medical Center, Omaha, NE; Ian W. Flinn and Richard F. Ambinder, Johns Hopkins University Oncology Center, Baltimore, MD; Joseph M. Connors, British Columbia Cancer Agency Centre for Lymphoid Cancer, Vancouver, British Columbia; Neil L. Berinstein, Toronto-Sunnybrook Regional Cancer Centre, Toronto, Ontario; Andrew R. Belch, Cross Cancer Institute, Edmonton, Alberta, Canada; Nancy L. Bartlett, Washington University School of Medicine, St Louis, MO; Craig Nichols, Oregon Health Science University, Portland, OR; Stephanie A. Gregory, Rush University Medical Center, Chicago, IL; Brian K. Link, University of Iowa Hospitals and Clinics, Iowa City, IA; David J. Inwards, Mayo Clinic, Rochester, MN; Arnold S. Freedman, Dana-Farber Cancer Institute, Boston, MA; and Jeffrey V. Matous, Rocky Mountain Cancer Centers, Denver, CO.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.43.9273DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4039868PMC
June 2014

Gastrointestinal stromal tumors, version 2.2014.

J Natl Compr Canc Netw 2014 Jun;12(6):853-62

From Fox Chase Cancer Center; Huntsman Cancer Institute at the University of Utah; The University of Texas MD Anderson Cancer Center; UC San Diego Moores Cancer Center; Moffitt Cancer Center; Memorial Sloan-Kettering Cancer Center; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; Massachusetts General Hospital Cancer Center; Stanford Cancer Institute; Dana-Farber/Brigham and Women's Cancer Center; University of Alabama at Birmingham Comprehensive Cancer Center; Roswell Park Cancer Institute; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; Fred & Pamela Buffett Cancer Center at The Nebraska Medical Center; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; UCSF Helen Diller Family Comprehensive Cancer Center; St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; City of Hope Comprehensive Cancer Center; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; Duke Cancer Institute; University of Michigan Comprehensive Cancer Center; Vanderbilt-Ingram Cancer Center; Robert H. Lurie Comprehensive Cancer Center of Northwestern University; and National Comprehensive Cancer Network.

View Article

Download full-text PDF

Source
http://www.jnccn.org/content/12/6/853.full.pdf
Web Search
http://dx.doi.org/10.6004/jnccn.2014.0080DOI Listing
June 2014

Soft tissue sarcoma, version 2.2014.

J Natl Compr Canc Netw 2014 Apr;12(4):473-83

From 1Fox Chase Cancer Center; 2Huntsman Cancer Institute at the University of Utah; 3The University of Texas MD Anderson Cancer Center; 4UC San Diego Moores Cancer Center; 5Moffitt Cancer Center; 6Memorial Sloan-Kettering Cancer Center; 7Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; 8Massachusetts General Hospital Cancer Center; 9Stanford Cancer Institute; 10Dana-Farber/Brigham and Women's Cancer Center; 11University of Alabama at Birmingham Comprehensive Cancer Center; 12Roswell Park Cancer Institute; 13The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; 14Fred & Pamela Buffett Cancer Center at The Nebraska Medical Center; 15The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; 16UCSF Helen Diller Family Comprehensive Cancer Center; 17St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; 18City of Hope Comprehensive Cancer Center; 19Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; 20Duke Cancer Institute; 21University of Michigan Comprehensive Cancer Center; 22Vanderbilt-Ingram Cancer Center; 23Robert H. Lurie Comprehensive Cancer Center of Northwestern University; and 24National Comprehensive Cancer Network.

View Article

Download full-text PDF

Source
http://www.jnccn.org/content/12/4/473.full.pdf
Web Search
http://dx.doi.org/10.6004/jnccn.2014.0053DOI Listing
April 2014

The treatment outcome for adult patients with Ewing's sarcoma.

Curr Oncol Rep 2013 Aug;15(4):372-7

Department of Medicine, Division of Oncology, Stanford Comprehensive Cancer Center, 875 Blake Wilbur Drive, Stanford, CA 94305, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-013-0317-5DOI Listing
August 2013

The prognostic value of tumor-associated macrophages in leiomyosarcoma: a single institution study.

Am J Clin Oncol 2011 Feb;34(1):82-6

Division of Oncology, Department of Medicine, Stanford University Medical Center, Stanford, CA, 94305, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4816680PMC
http://dx.doi.org/10.1097/coc.0b013e3181d26d5eDOI Listing
February 2011

Current and emerging pharmacological treatments for gastrointestinal stromal tumour.

Drugs 2011 Feb;71(3):321-30

Department of Medicine, Division of Oncology, Stanford Comprehensive Cancer Center, Stanford, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2165/11585370-000000000-00000DOI Listing
February 2011

New developments in targeted therapy for soft tissue sarcoma.

Authors:
Kristen N Ganjoo

Curr Oncol Rep 2010 Jul;12(4):261-5

Stanford University, 269 Campus Drive, Stanford, CA 94305, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11912-010-0107-2
Publisher Site
http://dx.doi.org/10.1007/s11912-010-0107-2DOI Listing
July 2010

Trabectedin: an anticancer drug from the sea.

Expert Opin Pharmacother 2009 Nov;10(16):2735-43

Stanford University, 875 Blake Wilbur Drive, Stanford, CA 94305, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14656560903277236DOI Listing
November 2009

The importance of angiogenesis markers in the outcome of patients with diffuse large B cell lymphoma: a retrospective study of 97 patients.

J Cancer Res Clin Oncol 2008 Mar 11;134(3):381-7. Epub 2007 Aug 11.

Division of Oncology, Stanford University, Stanford, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-007-0294-xDOI Listing
March 2008

Review of erlotinib in the treatment of advanced non-small cell lung cancer.

Biologics 2007 Dec;1(4):335-46

Palo Alto VA Heath Care Systems, Palo Alto, CA, USA;

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2721286PMC
December 2007

Phase II study of gemcitabine plus docetaxel in advanced pancreatic cancer: a Hoosier Oncology Group study.

Oncology 2003 ;65(3):218-23

Division of Hematology-Oncology, Indiana University Medical Center and Walther Cancer Institute, Indianapolis, IN 46202, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000074474DOI Listing
January 2004

Unusual locations of involvement by malignancies: Case 1. Testicular plasmacytoma.

J Clin Oncol 2003 Sep;21(17):3368-9

Indiana University School of Medicine, Indianapolis, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2003.09.049DOI Listing
September 2003

A phase I study of weekly gemcitabine and docetaxel in patients with advanced cancer: a Hoosier Oncology Group Study.

Oncology 2002 ;62(4):299-304

Department of Medicine, Division of Hematology/Oncology, Indiana University and The Walther Cancer Institute, Indianapolis, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000065060DOI Listing
August 2002